Mexico’s local pharma scene equals biotech products’ uptrend development
You probably are aware of this. If you aren’t you better believe it. Probiomed and Cryopharma lead the pack. And others known to be lead generic pharma developers in the region are dabbling into early stage biologic and biosimilar/bio-comparable development: Chinoin, IQFA, Birmex, Sangre de CordÃ³n, and Laboratorios Sophia.
The bio-comparable guidelines were set by COFEPRIS a year ago and in October these local Mexican biotech and biopharma companies will gather along with many others to talk about practical experience and updates on bio-comparable development.
How has it been since the bio-comparable guideline was set in May 2012? What are their challenges? What are their successes? What can be done to improve development? How can COFEPRIS implement guidelines better? What is reimbursement like?
Biopharma Mexico Convention in October bears it all. For more information log in to